Abstract:β-Arbutin is a plant-derived glycoside and widely used in cosmetic and pharmaceutical industries because of its safe and effective skin-lightening property as well as anti-oxidant, anti-microbial, and anti-inflammatory activities. In recent years, microbial fermentation has become a highly promising method for the production of β-arbutin. However, this method suffers from low titer and low yield, which has become the bottleneck for its widely industrial application. In this study, we used β-arbutin to demonstrate methods for improving yields for industrial-scale production in Escherichia coli. First, the supply of precursors phosphoenolpyruvate and uridine diphosphate glucose was improved, leading to a 4.6-fold increase in β-arbutin production in shaking flasks. The engineered strain produced 36.12 g/L β-arbutin with a yield of 0.11 g/g glucose in a 3-L bioreactor. Next, based on the substrate and product's structural similarity, an endogenous O-acetyltransferase was identified as responsible for 6-O-acetylarbutin formation for the first time. Eliminating the formation of byproducts, including 6-O-acetylarbutin, tyrosine, and acetate, resulted in an engineered strain producing 43.79 g/L β-arbutin with a yield of 0.22 g/g glucose in fed-batch fermentation. Thus, the yield increased twofold by eliminating byproducts formation. To the best of our knowledge, this is the highest titer and yield of β-arbutin ever reported, paving the way for the industrial production of β-arbutin. This study demonstrated a systematic strategy to alleviate undesirable byproduct accumulation and improve the titer and yield of target products. KEY POINTS: • A systematic strategy to improve titer and yield was showed • Genes responsible for 6-O-acetylarbutin formation were firstly identified • 43.79 g/L β-arbutin was produced in bioreactor, which is the highest titer so far.

Recent Progress on Feasible Strategies for Arbutin Production

[Research progress in biosynthesis of arbutin]

Recent progress on biological production of α-arbutin

Biotechnological production of arbutins (α- and β-arbutins), skin-lightening agents, and their derivatives

High-level De Novo Biosynthesis of Arbutin in Engineered Escherichia Coli

High-yield production of β-arbutin by identifying and eliminating byproducts formation

Strain Screen and Condition Optimization of Synthesis Arbutin by Fermentation

Arbutin as a Skin Depigmenting Agent with Antimelanogenic and Antioxidant Properties

Natural deep eutectic solvent enhanced pulse-ultrasonication assisted extraction as a multi-stability protective and efficient green strategy to extract anthocyanin from blueberry pomace

De novo biosynthesis of β-Arbutin in Komagataella phaffii based on metabolic engineering strategies

Strategy for anthocyanins production: From efficient green extraction to novel microbial biosynthesis

Development in Synthesis of Arbutin

Enhanced Biosynthesis of Arbutin by Engineering Shikimate Pathway in Pseudomonas Chlororaphis P3

Engineering Yarrowia Lipolytica for Enhanced Production of Arbutin

De Novo Biosynthesis of Β-Arbutin in Corynebacterium Glutamicum Via Pathway Engineering and Process Optimization

Optimization of whole-cell biotransformation for scale-up production of α-arbutin from hydroquinone by the use of recombinant Escherichia coli

A New Synthesis of Α-Arbutin Via Lewis Acid Catalyzed Selective Glycosylation of Tetra-O-benzyl-α-d-glucopyranosyl Trichloroacetimidate with Hydroquinone

Screening of Microorganisms Catalyzing the Biosynthesis of Arbutin

Biotechnological Production of Astaxanthin Through Metabolic Engineering of Yeasts

Arbutin Encapsulated Micelles Improved Transdermal Delivery and Suppression of Cellular Melanin Production

[Molecular modification of cyclodextrin glucosyltransferase and its application in the synthesis of α-arbutin]